What will the Boston life sciences landscape look like twenty years from now? Will this area remain the world’s leader in university and corporate research, venture financing, and entrepreneurial activity? Will local firms be dominating a marketplace built around personalized medicine, RNAi-based drugs, and stem-cell therapies? Will the ever-increasing competition from other states and nations have leveled the playing field?
We’re assembling a select group of life sciences innovators and thinkers to talk about these and other key questions in an invitation-only event. This intimate conversation will be led by:
Phillip Sharp
Institute Professor MIT, Nobel Prize winner, co-founder of Biogen, Alnylam Pharmaceuticals, and Magen Biosciences
Noubar Afeyan
Co-founder, managing partner, and CEO, Flagship Ventures
Raju Kucherlapati
Scientific director, Harvard Partners Center for Genetics and Genomics, professor of genetics and medicine, Harvard Medical School
Note: To ensure that everybody has a chance to participate in the discussion we’re only selling a limited number of tickets (at $50 apiece) for this Xconomy Forum. If you would like to attend, please e-mail us at [email protected] and tell us a bit about yourself and your interest in the event. If we can accommodate you (and we apologize if we can’t) we’ll reply with instructions for registering online.
